Cargando…
The challenge of removal of sepsis markers by continuous hemofiltration
Autores principales: | Honore, Patrick M., De Bels, David, Attou, Rachid, Redant, Sebastien, Kashani, Kianoush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521397/ https://www.ncbi.nlm.nih.gov/pubmed/31092274 http://dx.doi.org/10.1186/s13054-019-2464-z |
Ejemplares similares
-
Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019) -
Influence of pathogen and focus of infection on procalcitonin values in sepsis: are there additional confounding factors?
por: Honore, Patrick M., et al.
Publicado: (2019) -
Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019) -
Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia?
por: Honore, Patrick M., et al.
Publicado: (2018) -
Attainment of therapeutic vancomycin level within the first 24 h
por: Honore, Patrick M., et al.
Publicado: (2019)